logo

HHS

Harte Hanks·NASDAQ
--
--(--)
--
--(--)
0.35 / 10
Underperform

Harte Hanks' fundamental position is fragile. Key issues include a negative PB-ROE factor (-0.7532) and a low Net assets per share growth rate (-9.05% YoY), both placing them in lower-performing quartiles. Although Revenue-MV is strong, it is offset by weaknesses in Cash-MV and Asset-MV, leading to an overall defensive rating and an Underperform fundamental score.

Fundamental(0.35)SentimentTechnical

Analysis Checks(5/10)

Revenue-MV
Value1.81
Score2/3
Weight-42.62%
1M Return1.21%
Net assets per share (growth rate compared to beginning of year %)
Value-9.05
Score1/3
Weight21.20%
1M Return-0.73%
Operating cycle
Value69.75
Score2/3
Weight-0.44%
1M Return0.01%
Profit-MV
Value0.46
Score1/3
Weight29.30%
1M Return-1.02%
Net income-Revenue
Value-0.17
Score3/3
Weight-99.39%
1M Return3.47%
PB-ROE
Value-0.75
Score1/3
Weight26.12%
1M Return-0.89%
Cash-UP
Value-0.06
Score2/3
Weight65.96%
1M Return-2.65%
Asset-MV
Value-0.50
Score1/3
Weight-13.10%
1M Return0.35%
Inventory turnover days
Value232.28
Score2/3
Weight2.60%
1M Return-0.09%
Cash-MV
Value0.69
Score0/3
Weight110.37%
1M Return-4.69%
Is HHS undervalued or overvalued?
  • HHS scores 0.35/10 on fundamentals and holds a Premium valuation at present. Backed by its -14.50% ROE, -3.26% net margin, -7.20 P/E ratio, 1.09 P/B ratio, and 82.20% earnings growth, these metrics solidify its Underperform investment rating.